Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

AUSTRALIA'S RAMSAY HEALTH CARE POSTS 13PCT FALL IN NET PROFIT

Sun. August 24, 2008; Posted: 08:39 PM
Stocks RSS
MELBOURNE, Aug 25, 2008 (AsiaPulse via COMTEX) -- RHCRF | Quote | Chart | News | PowerRating -- Private hospitals operator Ramsay Health Care Ltd (ASX:RHC) says it is targeting core earnings per share (EPS) growth of 10 to 12 per cent this financial year.

Ramsay today booked a net profit for the year ended June 30, 2008, of $A92.2 million ($US79.85 million), down 13.88 per cent on the prior year.

But core net profit from continuing operations lifted 11.54 per cent to $123.1 million.

"Ramsay is targeting core EPS growth of 10-12 per cent for the total group for the 2009 financial year, with strong health care fundamentals and organic growth set to continue," the company said today.

Ramsay said it was operating in a growth industry with strong fundamentals at home and abroad and was confident of its future.

Future growth would be underpinned by the ageing population and increasing life expectancy.

Ramsay was focused on organic growth, brownfields expansion and acquisitions.

"Ramsay remains committed to undertaking brownfields investment opportunities in Australia," the company said.

"All major brownfield projects have been reassessed in light of recently announced changes to the healthcare environment.

"Following this reassessment, Ramsay remains confident about the program and the future earnings it can deliver."

Ramsay said that in the United Kingdom, it was focused on developing and strengthening the business and would continue to investigate opportunities for capacity expansion and bolt-on acquisitions.

Ramsay said the UK group had outperformed expectations in the 2008 financial year and was expected to be EPS-accretive in the 2009 financial year - one year ahead of schedule.

Ramsay said that core net profit, which included a 7.5 month contribution from Ramsay UK, delivered core earnings per share of 60.7 cents for the full year, up 11.8 per cent on the prior year and at the upper end of Ramsay's guidance of 10-12 per cent.

Ramsay's bottom-line result included specific items of $26.5 million, comprising the non-cash portion of rental expense for the UK hospitals, restructuring and integration costs and a write-off of unamortised capitalised borrowing costs from an earlier refinancing.

Operating revenue from continuing operations rose 27.38 per cent to $2.67 billion.

The company declared a final dividend of 17.5 cents per share, compared to 16 cents in the prior year.

The total dividend for the year was 32.5 cents per share, compared to 29 cents in the prior year.

Ramsay managing director Chris Rex said the result was "very solid", reflecting strong organic growth across the Australian and Indonesian portfolio and a better-than-expected performance from the UK.

"Overall, we are very pleased with the underlying performance of the business and Ramsay is very well positioned for future growth," he said.

On a like-for-like basis, Ramsay's Australian and Indonesian core net profit rose 12.5 per cent to $124.2 million.

Mr Rex said the contribution from Ramsay UK exceeded expectations, with NHS (National Health Service) activity coming in ahead of budget.

"With the government's firm commitment to NHS reforms and `patient choice' to be enshrined in legislation, we are very excited about our future in the UK, and we will continue to look for capacity expansion and bolt-on acquisition opportunities that add value to our business," he said.

Ramsay said that operations in Australia and Indonesia had achieved solid earnings before interest and tax (EBIT) growth of 11.0 per cent, reflecting an improved performance across the portfolio

Earnings before interest, tax, depreciation and amortisation (EBITDA) hospital margins for Australia and Indonesia were steady at 15.3 per cent.

Total admissions in Australia grew 4.5 per cent during the period.

"A number of Ramsay's Australian hospitals are now operating at capacity and cannot meet demand," the company said.

Integration of Ramsay UK was proceeding well and the business was performing better than expected, with NHS work continuing to grow in private hospitals and now comprising more than 30 per cent of admissions, up from ten per cent a year ago.

Growing NHS demand and the government's commitment to its reforms has bolstered Ramsay's confidence to expand capacity.

Brownfield capital expenditure of STG28 million ($A59.83 million) had already been committed since the acquisition of Ramsay UK.

Operating margins before rent remained strong, at more than 20 per cent.

Ramsay said it had a board-approved commitment of $550 million for improvements and capacity expansion in Australia, of which about $200 million already had been spent.

(AAP)

For full details for RHCRF click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.